Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A comparative study on the improvement of quality of life of colostomized patients using the new Be1 device with capsule system.
The primary objective is to demonstrate improvement of quality of life (difference of at least 5 points in the StomaQoL questionnaire) among descending colostomy patients, establishing the following comparisons:
The following secondary objectives have been defined:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Stomatherapy | Device | Demonstrate improvement of quality of life (difference of at least 5 points in the StomaQoL questionnaire (21)) among descending colostomy patients, establishing the following comparisons. |
| Measure | Description | Time Frame |
|---|---|---|
| StomaQoL | to demonstrate improvement of quality of life (difference of at least 5 points in the StomaQoL questionnaire) among descending colostomy patients | 1 month |
| Measure | Description | Time Frame |
|---|---|---|
| Questionnaire | Assessment of patient satisfaction with the new Be1 device with capsule system versus a current two-piece mechanical device. | 1 month |
| Biota Analysis | Demonstration that the new Be1 device with capsule system improves the microbiota of the colostomized patient |
Not provided
Inclusion Criteria:
- Inclusion criteria groups 1 and 2
Inclusion criteria group 3
Exclusion Criteria:
Exclusion criteria groups 1 and 2
Exclusion criteria group 3
Not provided
Not provided
Not provided
The study will involve descending colostomy patients. There are three study groups. Two of them will comprise new patients (recently subjected to surgery), while the third will consist of patients with an ostomy for at least 6 months (pre-existing patients).
The sample size will comprise 240 patients (85 patients in the mentioned two groups and 70 in the third).
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| MM | Contact |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 month |